Opsens named to the TSX Venture Top 50
QUEBEC, QUEBEC, February 12, 2014. Opsens Inc. (TSXV:OPS) (the “Company” or “Opsens”) was today named a 2014 TSX Venture 50® company by the TMX Group. The TSX Venture 50® ranks the top 10 companies in five major industry sectors, identifying emerging companies that have shown strong results in key measures of market performance. Opsens was ranked among the top Canadian Technology and Life Sciences companies.
In the past few months, Opsens has made leaps toward its goal to commercialize its first medical instrumentation products that measure Fractional Flow Reserve (“FFR”) in patients suffering from coronary artery disease. In January, Opsens’ products were submitted for approval in Japan. On February 10, Opsens announced it had entered into an underwriting agreement with a syndicate of underwriters led by RBC Capital Markets and including Paradigm Capital Inc., for an $8 million equity financing, giving Opsens the financial means to launch its FFR products into this fast-growing market during the first quarter of calendar year 2015. “Opsens will soon file for 510(k) approval in the US and perform its first in-man study with its FFR products and will conclude filing requirements with Canada and CE Marking approval in Europe in the next few quarters” stated Louis Laflamme, president and CEO.
The 2014 TSX Venture 50® companies were selected based on four equally weighted criteria that include share price appreciation, trading volume, market capitalization growth and analyst coverage growth in the Clean Technology, Mining, Oil & Gas, Diversified Industries Technology and Life Sciences sectors.
About Opsens Inc. (www.opsens.com)
Focusing on two main growth markets, oil and gas and FFR in medical instrumentation, Opsens develops, manufactures and installs systems to measure pressure, temperature and others parameters using fiber optic sensing technologies. These systems are designed around patented technologies that are effective and durable in extreme conditions.
Forward-looking statements contained in this press release involve known and unknown risks, uncertainties and other factors that may cause actual results, performance and achievements of Opsens to be materially different from any future results, performance or achievements expressed or implied by the said forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Thierry Dumas, CPA, CA, Chief Financial Officer, 418.682.9996
Louis Laflamme, CPA, CA, President and Chief Executive Officer, 418.682.9996